Hyperhidrosis pp 197-202 | Cite as

Management of Compensatory Hyperhidrosis

  • Dafne Braga Diamante Leiderman
  • Guilherme Yazbec
  • Nelson Wolosker


Compensatory hyperhidrosis (CH) is the most common and most feared adverse effect of thoracic sympathectomy and the complaint is mainly of increased sweat of the chest, abdomen, legs, and buttocks. Studies show that practically all patients will have some degree of this complication, but more than 11.6% of patients develop a severe CH with a social impact as bad or worse than the preoperative status. The first-line treatment is the oral use of anticholinergic medications, mainly oxybutynin.


Compensatory hyperhidrosis Oxybutynin Sympathectomy Sweat 

Suggested Reading

  1. de Campos JR, Wolosker N, Takeda FR, et al. The body mass index and level of resection: predictive factors for compensatory sweating after sympathectomy. Clin Auton Res. 2005;15(2):116–20.CrossRefGoogle Scholar
  2. Gong TK, Kim DW. Effectiveness of oral glycopyrrolate use in compensatory hyperhidrosis patients. Korean J Pain. 2013;26(1):89–93.CrossRefGoogle Scholar
  3. Lowe N, Campanati A, Bodokh I, et al. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Br J Dermatol. 2004;151(6):1115–22.CrossRefGoogle Scholar
  4. Milanez de Campos JR, Kauffman P, Gomes O Jr, Wolosker N. Video-assisted thoracic sympathectomy for hyperhidrosis. Thorac Surg Clin. 2016;26(3):347–58.CrossRefGoogle Scholar
  5. Prouty ME, Fischer R, Liu D. Glycopyrrolate-induced craniofacial compensatory hyperhidrosis successfully treated with oxybutynin: report of a novel adverse effect and subsequent successful treatment. Dermatol Online J. 2016;22(10):15.Google Scholar
  6. Teivelis MP, Varella AY, Wolosker N. Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis. J Thorac Cardiovasc Surg. 2014;148(5):2443–4.CrossRefGoogle Scholar
  7. Teivelis MP, Wolosker N, Krutman M, et al. Compensatory hyperhidrosis: results of pharmacologic treatment with oxybutynin. Ann Thorac Surg. 2014;98(5):1797–802.CrossRefGoogle Scholar
  8. Wolosker N, Yazbek G, Ishy A, et al. Is sympathectomy at T4 level better than at T3 level for treating palmar hyperhidrosis? J Laparoendosc Adv Surg Tech A. 2008;18(1):102–6.CrossRefGoogle Scholar
  9. Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106–12.CrossRefGoogle Scholar
  10. Yazbek G, Wolosker N, Kauffman P, et al. Twenty months of evolution following sympathectomy on patients with palmar hyperhidrosis: sympathectomy at the T3 level is better than at the T2 level. Clinics (Sao Paulo). 2009;64(8):743–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Dafne Braga Diamante Leiderman
    • 1
  • Guilherme Yazbec
    • 2
  • Nelson Wolosker
    • 2
  1. 1.Department of Vascular and Endovascular SurgeryHospital Israelita Albert EinsteinSão PauloBrazil
  2. 2.Department of Vascular and Endovascular SurgeryA.C. Camargo Cancer Center, LiberdadeSão PauloBrazil

Personalised recommendations